SLSN (Solesence) Change In Payables And Accrued Expense : $6.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is Solesence Change In Payables And Accrued Expense?

Solesence's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was $-0.24 Mil. It means Solesence's Accounts Payable & Accrued Expense declined by $0.24 Mil from Dec. 2024 to Mar. 2025 .

Solesence's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was $6.39 Mil. It means Solesence's Accounts Payable & Accrued Expense increased by $6.39 Mil from Dec. 2023 to Dec. 2024 .

Solesence Change In Payables And Accrued Expense Historical Data

The historical data trend for Solesence's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solesence Change In Payables And Accrued Expense Chart

Solesence Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.41

1.51

1.90

-0.65

6.39

Solesence Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.15	-0.40	2.60	4.04	-0.24

Solesence Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.00 Mil.

Solesence Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Solesence's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Solesence Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Solesence Inc (NAS:SLSN) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1319 Marquette Drive, Romeoville, IL, USA, 60446

Website

https://www.solesence.com

Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.

Executives

R Janet Whitmore	director
Kevin Cureton	officer: VP, Sales & Marketing & BD	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Bradford T Whitmore	10 percent owner	5215 OLD ORCHARD ROAD, SUITE 620, SKOKIE IL 60077
Jess Jankowski	officer: Chief Financial Officer
Mark E Miller	director	1319 MARQUETTE DR, ROMEOVILLE IL 60446
Strandler, Llc	10 percent owner	401 3RD STREET, #9, RAPID CITY SD 57701
Laura M Beres	director	1319 MARQUETTE DR, ROMEOVILLE IL 60446
Jaime Escobar	officer: Chief Financial Officer	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Frank Cesario	officer: Chief Financial Officer	C/O ISCO INTERNATIONAL INC, 451 KIGSTON COURT, MT PROSPECT IL 60056
James A Henderson	director	301 WASHINGTON ST, COLUMBUS IN 47201
George A Vincent	director	C/O NANOPHASE TECHNOLOGIES, 1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Spurgeon Corp	10 percent owner	407 S. THIRD STREET, SUITE 230, GENEVA IL 60134
W Edwin Tyler	director	ONE NORTH WACKER DRIVE, SUITE 4200, CHICAGO IL 60606
Nancy Baldwin	officer: VP Human Resources & IT	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446
Patrick G Murray	officer: VP Research & Development	1319 MARQUETTE DRIVE, ROMEOVILLE IL 60446